Screener
Neuropace, Inc. NPCE Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Neuropace, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s price / sales?
- Neuropace, Inc. (NPCE) reported price / sales of 5.5× in Q2 2026.
- How has Neuropace, Inc.'s price / sales changed year-over-year?
- Neuropace, Inc.'s price / sales increased by 31.3% year-over-year, from 4.2× to 5.5×.
- What is the long-term trend for Neuropace, Inc.'s price / sales?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s price / sales has grown at a -0.3% compound annual growth rate (CAGR), from 5.4× to 5.4×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Neuropace, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude